Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 6.565 USD -3.03% Market Closed
Market Cap: 498.5m USD
Have any thoughts about
Chromadex Corp?
Write Note

Intrinsic Value

The intrinsic value of one CDXC stock under the Base Case scenario is 2.235 USD. Compared to the current market price of 6.565 USD, Chromadex Corp is Overvalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CDXC Intrinsic Value
2.235 USD
Overvaluation 66%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Chromadex Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CDXC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CDXC?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Chromadex Corp

Provide an overview of the primary business activities
of Chromadex Corp.

What unique competitive advantages
does Chromadex Corp hold over its rivals?

What risks and challenges
does Chromadex Corp face in the near future?

Summarize the latest earnings call
of Chromadex Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Chromadex Corp.

Provide P/S
for Chromadex Corp.

Provide P/E
for Chromadex Corp.

Provide P/OCF
for Chromadex Corp.

Provide P/FCFE
for Chromadex Corp.

Provide P/B
for Chromadex Corp.

Provide EV/S
for Chromadex Corp.

Provide EV/GP
for Chromadex Corp.

Provide EV/EBITDA
for Chromadex Corp.

Provide EV/EBIT
for Chromadex Corp.

Provide EV/OCF
for Chromadex Corp.

Provide EV/FCFF
for Chromadex Corp.

Provide EV/IC
for Chromadex Corp.

Show me price targets
for Chromadex Corp made by professional analysts.

What are the Revenue projections
for Chromadex Corp?

How accurate were the past Revenue estimates
for Chromadex Corp?

What are the Net Income projections
for Chromadex Corp?

How accurate were the past Net Income estimates
for Chromadex Corp?

What are the EPS projections
for Chromadex Corp?

How accurate were the past EPS estimates
for Chromadex Corp?

What are the EBIT projections
for Chromadex Corp?

How accurate were the past EBIT estimates
for Chromadex Corp?

Compare the revenue forecasts
for Chromadex Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Chromadex Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Chromadex Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Chromadex Corp compared to its peers.

Compare the P/E ratios
of Chromadex Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Chromadex Corp with its peers.

Analyze the financial leverage
of Chromadex Corp compared to its main competitors.

Show all profitability ratios
for Chromadex Corp.

Provide ROE
for Chromadex Corp.

Provide ROA
for Chromadex Corp.

Provide ROIC
for Chromadex Corp.

Provide ROCE
for Chromadex Corp.

Provide Gross Margin
for Chromadex Corp.

Provide Operating Margin
for Chromadex Corp.

Provide Net Margin
for Chromadex Corp.

Provide FCF Margin
for Chromadex Corp.

Show all solvency ratios
for Chromadex Corp.

Provide D/E Ratio
for Chromadex Corp.

Provide D/A Ratio
for Chromadex Corp.

Provide Interest Coverage Ratio
for Chromadex Corp.

Provide Altman Z-Score Ratio
for Chromadex Corp.

Provide Quick Ratio
for Chromadex Corp.

Provide Current Ratio
for Chromadex Corp.

Provide Cash Ratio
for Chromadex Corp.

What is the historical Revenue growth
over the last 5 years for Chromadex Corp?

What is the historical Net Income growth
over the last 5 years for Chromadex Corp?

What is the current Free Cash Flow
of Chromadex Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Chromadex Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chromadex Corp

Current Assets 52.1m
Cash & Short-Term Investments 32.2m
Receivables 7.1m
Other Current Assets 12.8m
Non-Current Assets 4.4m
PP&E 3.6m
Intangibles 397k
Other Non-Current Assets 374k
Current Liabilities 17.7m
Accounts Payable 6.9m
Accrued Liabilities 10.6m
Other Current Liabilities 196k
Non-Current Liabilities 4.5m
Long-Term Debt 2k
Other Non-Current Liabilities 4.5m
Efficiency

Earnings Waterfall
Chromadex Corp

Revenue
91.7m USD
Cost of Revenue
-35.3m USD
Gross Profit
56.3m USD
Operating Expenses
-55.9m USD
Operating Income
447k USD
Other Expenses
1m USD
Net Income
1.5m USD

Free Cash Flow Analysis
Chromadex Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CDXC Profitability Score
Profitability Due Diligence

Chromadex Corp's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
ROIC is Increasing
Positive Revenue Growth Forecast
35/100
Profitability
Score

Chromadex Corp's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

CDXC Solvency Score
Solvency Due Diligence

Chromadex Corp's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
80/100
Solvency
Score

Chromadex Corp's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CDXC Price Targets Summary
Chromadex Corp

Wall Street analysts forecast CDXC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDXC is 6.809 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

Lowest
Price Target
6.06 USD
8% Downside
Average
Price Target
6.809 USD
4% Upside
Highest
Price Target
8.4 USD
28% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CDXC?

Click here to dive deeper.

Dividends

Chromadex Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for CDXC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Chromadex Corp Logo
Chromadex Corp

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

499.1m USD

Dividend Yield

0%

Description

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

Contact

CALIFORNIA
Los Angeles
10900 Wilshire Blvd Ste 600
+13103886706.0
chromadex.com

IPO

2007-06-25

Employees

115

Officers

Co-Founder & Chairman
Mr. Frank Louis Jaksch Jr.
CEO & Director
Mr. Robert N. Fried
Executive Officer
Ms. Brianna Gerber
CFO & Principal Accounting Officer
Mr. Ozan Pamir C.F.A.
Senior Vice President of Global Regulatory & Scientific Affairs
Dr. Andrew Shao Ph.D.
Senior VP & General Counsel
Mr. Carlos Lopez
Show More
Vice President of Global Marketing & Communications
Alex Worsham
Managing Director of Asia Pacific
Ms. Chu Yan
Head of Media Relations & Partnerships
Kendall Knysch
Controller
Mr. James Lee
Show Less

See Also

Discover More
What is the Intrinsic Value of one CDXC stock?

The intrinsic value of one CDXC stock under the Base Case scenario is 2.235 USD.

Is CDXC stock undervalued or overvalued?

Compared to the current market price of 6.565 USD, Chromadex Corp is Overvalued by 66%.

Back to Top